MTOR and diabetes mellitus: Immunosuppressants and/or antineoplastics such as inhibitors of mammalian target of rapamycin (mTOR), calcineurin inhibitors, and glucocorticoids promote insulin resistance, worsen glycaemia, and/or increase the risk of diabetes [17, 18, 44, 45].